Hidradenitis suppurativa:: are tumour necrosis factor-α blockers the ultimate alternative?

被引:41
|
作者
Brunasso, A. M. G. [2 ,3 ]
Delfino, C. [3 ]
Massone, C. [1 ]
机构
[1] Med Univ Graz, Res Unit Dermatopathol, Dept Dermatol, A-8036 Graz, Austria
[2] Galliera Hosp, Dept Dermatol, Genoa, Italy
[3] Univ Florence, Sch Med, Dept Dermatol Sci, Florence, Italy
关键词
hidradenitis suppurativa; infliximab; tumour necrosis factor-alpha;
D O I
10.1111/j.1365-2133.2008.08735.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:761 / 763
页数:4
相关论文
共 50 条
  • [21] Comment on: "Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?"
    Pestana, Mafalda
    Brito Caldeira, Margarida
    Cabete, Joana
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (04) : 591 - 592
  • [22] Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”
    Mafalda Pestana
    Margarida Brito Caldeira
    Joana Cabete
    American Journal of Clinical Dermatology, 2022, 23 : 591 - 592
  • [23] Comment on: Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-α blockers: perioperative interruption of tumour necrosis factor-α blockers decreases complications? reply
    Momohara, Shigeki
    Kawakami, Kosei
    Kawamura, Koichiro
    Iwamoto, Takuji
    Yano, Koichiro
    Sakuma, Yu
    Tokita, Asami
    Ikari, Katsunori
    RHEUMATOLOGY, 2010, 49 (06) : 1210 - 1210
  • [24] Anti tumor necrosis factor alpha in hidradenitis suppurativa
    Martin-Vila, A.
    Alvarez-Payero, M.
    Martinez-Lopez de Castro, N.
    Sanmartin-Alvarez, S.
    Perez-Parente, D.
    Ucha-Samartin, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 986 - 987
  • [25] Tumour Necrosis Factor-alpha and Matrix Metalloproteinase-2 are Expressed Strongly in Hidradenitis Suppurativa
    Mozeika, Elga
    Pilmane, Mara
    Nurnberg, Birgit Meinecke
    Jemec, Gregor B. E.
    ACTA DERMATO-VENEREOLOGICA, 2013, 93 (03) : 301 - 304
  • [26] EXPRESSION OF TUMOUR NECROSIS FACTOR-α CONVERTING ENZYME AND TUMOUR NECROSIS FACTOR-α IN RATS WITH ALCOHOLIC CARDIOMYOPATHY
    Li Jianqiang
    Li Weimin
    Li Yue
    Zhao Jiyi
    Kong Yihui
    Guo Hong
    Xue Jingyi
    Sheng Li
    Gong Yongtai
    Xue Hongjie
    HEART, 2010, 96 : A49 - A50
  • [27] TNF-α blockers for hidradenitis suppurativa
    Massarotti, E
    Sobell, J
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S133 - S133
  • [28] Tumour necrosis factor-α blockers:: potential limitations in the management of advanced endometriosis?: A case report
    Shakiba, Khashayar
    Falcone, Tommaso
    HUMAN REPRODUCTION, 2006, 21 (09) : 2417 - 2420
  • [29] Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alpha
    Marques, E.
    Arenberger, P.
    Smetanova, A.
    Gkalpakiotis, S.
    Zimova, D.
    Arenbergerova, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (05) : 966 - 967
  • [30] Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study
    van der Zee, H. H.
    Laman, J. D.
    de Ruiter, L.
    Dik, W. A.
    Prens, E. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (02) : 298 - 305